Ole-Bjørn Tysnes

Affiliations: 
Department of Neurology University of Bergen, Norway, Bergen, Hordaland, Norway 
Google:
"Ole-Bjørn Tysnes"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu G, Peng J, Liao Z, et al. (2021) Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nature Genetics
Ongre SO, Dalen I, Tysnes OB, et al. (2020) Progression of fatigue in Parkinson's disease - a 9-year follow-up. European Journal of Neurology. 28: 108-116
Kusters CDJ, Paul KC, Duarte Folle A, et al. (2020) Genetic risk scores and hallucinations in patients with Parkinson disease. Neurology. Genetics. 6: e492
Ramsay N, Macleod AD, Alves G, et al. (2020) Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease. Parkinsonism & Related Disorders. 76: 49-53
Nido GS, Dick F, Toker L, et al. (2020) Common gene expression signatures in Parkinson's disease are driven by changes in cell composition. Acta Neuropathologica Communications. 8: 55
Erga AH, Alves G, Tysnes OB, et al. (2019) Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease. Journal of Neurology
Hiorth YH, Pedersen KF, Dalen I, et al. (2019) Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study. Neurology
Iwaki H, Blauwendraat C, Leonard HL, et al. (2019) Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. Movement Disorders : Official Journal of the Movement Disorder Society
Iwaki H, Blauwendraat C, Leonard HL, et al. (2019) Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. Neurology. Genetics. 5: e348
Førland MG, Tysnes OB, Aarsland D, et al. (2019) The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology. European Journal of Neurology
See more...